Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | 5-Bromo-2-(piperidin-1-yl)pyrimidine | HCID 3614682 | — |
| Reactant | 3-Cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[D]azepin-7-OL | HCID 10082081 | — |
| Catalyst | copper(I) bromide | HCID 24593 | — |
| Solvent | Pyridine | HCID 1049 | — |
| Product | HCID 10452270 | HCID 10452270 | — |
Reaction Steps
Sodium hydride (60% disp. in mineral oil, 44 mg, 1.1 mmol) was added to a stirred solution of 3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-ol (E3) (200 mg, 0.92 mmol) and copper (I) bromide (184 mg, 1.3 mmol) in pyridine (10 ml) at 0° C. After stirring for 0.5 hour at room temperature, 5-bromo-2-(1-piperidinyl)pyrimidine (D32) (0.669 g, 2.8 mmol) was added and the reaction mixture heated at reflux for 2 hours. The reaction was allowed to cool, filtered and the filtrate was concentrated in vacuo. The crude residue was dissolved with ethyl acetate and washed with water and brine. The organic layer was dried (magnesium sulfate), filtered and concentrated in vacuo. Purification of the resulting residue by column chromatography eluting with a mixture of 0.880 ammonia:ethanol:dichloromethane (0.25:2.25:97.5 to 1:9:90) afforded the title compound (E140). MS (ES+) m/e 379 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07704994B2 |
|---|
| Source dataset | uspto-grants-2010_04 |
|---|
| ORD ID | ord-35a2311573be4deab209d6335ee3727b |
|---|
| Source note | uspto-grants-2010_04 |
|---|